SOPHiA GENETICS Reports Financial Results for the Third Quarter of Fiscal 2022
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
SOPHiA GENETICS SA (SOPH) Reports In-Line Q3 EPS
November 8, 2022 7:27 AM ESTSOPHiA GENETICS SA (NASDAQ: SOPH) reported Q3 EPS of ($0.36), in-line with the analyst estimate of ($0.36). Revenue for the quarter came in at $11.6 million versus the consensus estimate of $11.45 million.
2022 Outlook:
We are reaffirming our previously provided guidance of constant... More
